(19)
(11) EP 2 888 279 A1

(12)

(43) Date of publication:
01.07.2015 Bulletin 2015/27

(21) Application number: 13750350.4

(22) Date of filing: 20.08.2013
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
(86) International application number:
PCT/EP2013/067271
(87) International publication number:
WO 2014/029752 (27.02.2014 Gazette 2014/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 22.08.2012 US 201261691933 P
11.09.2012 US 201261699323 P

(71) Applicant: Glaxo Group Limited
Middlesex TW8 9GS (GB)

(72) Inventors:
  • GRIGGS, Jeremy
    Stevenage Hertfordshire SG1 2NY (GB)
  • LEWIS, Alan Peter
    Stevenage Hertfordshire SG1 2NY (GB)
  • WATTAM, Trevor Anthony Kenneth
    Stevenage Hertfordshire SG1 2NY (GB)

(74) Representative: Lee, Alison Lesley 
GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) ANTI LRP6 ANTIBODIES